SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-022924
Filing Date
2019-11-12
Accepted
2019-11-12 16:18:46
Documents
52
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0919_intecpharma.htm 10-Q 366817
2 SALES AGREEMENT BETWEEN INTEC PHARMA LTD. AND COWEN AND COMPANY, LLC DATED MARCH f10q0919ex10-1_intecpharma.htm EX-10.1 207292
3 CERTIFICATION f10q0919ex31-1_intecpharma.htm EX-31.1 12551
4 CERTIFICATION f10q0919ex31-2_intecpharma.htm EX-31.2 11610
5 CERTIFICATION f10q0919ex32-1_intecpharma.htm EX-32.1 4215
6 CERTIFICATION f10q0919ex32-2_intecpharma.htm EX-32.2 4153
  Complete submission text file 0001213900-19-022924.txt   2422388

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE ntec-20190930.xml EX-101.INS 332920
8 XBRL SCHEMA FILE ntec-20190930.xsd EX-101.SCH 41123
9 XBRL CALCULATION FILE ntec-20190930_cal.xml EX-101.CAL 47102
10 XBRL DEFINITION FILE ntec-20190930_def.xml EX-101.DEF 97797
11 XBRL LABEL FILE ntec-20190930_lab.xml EX-101.LAB 222251
12 XBRL PRESENTATION FILE ntec-20190930_pre.xml EX-101.PRE 166911
Mailing Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512
Business Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512 97225864657
Intec Pharma Ltd. (Filer) CIK: 0001638381 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37521 | Film No.: 191209695
SIC: 2834 Pharmaceutical Preparations